These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 12912689
21. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Van Quill KR, Dioguardi PK, Tong CT, Gilbert JA, Aaberg TM, Grossniklaus HE, Edelhauser HF, O'Brien JM. Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791 [Abstract] [Full Text] [Related]
28. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Griffin GC, Shields JA. Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042 [Abstract] [Full Text] [Related]
29. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944 [Abstract] [Full Text] [Related]
30. Preliminary results of primary chemotherapy in retinoblastoma. Bornfeld N, Schüler A, Bechrakis N, Henze G, Havers W. Klin Padiatr; 1997 Aug; 209(4):216-21. PubMed ID: 9293453 [Abstract] [Full Text] [Related]
35. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre. Künkele A, Jurklies C, Wieland R, Lohmann D, Bornfeld N, Eggert A, Schulte JH. Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458 [Abstract] [Full Text] [Related]